BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23567263)

  • 1. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
    Cariaga-Martinez AE; López-Ruiz P; Nombela-Blanco MP; Motiño O; González-Corpas A; Rodriguez-Ubreva J; Lobo MV; Cortés MA; Colás B
    Cell Signal; 2013 Jul; 25(7):1586-97. PubMed ID: 23567263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.
    Lee MW; Kim DS; Lee JH; Lee BS; Lee SH; Jung HL; Sung KW; Kim HT; Yoo KH; Koo HH
    Cancer Sci; 2011 Oct; 102(10):1822-8. PubMed ID: 21722267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt isoform-specific inhibition of MDA-MB-231 cell proliferation.
    Yang W; Ju JH; Lee KM; Shin I
    Cell Signal; 2011 Jan; 23(1):19-26. PubMed ID: 20688159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
    Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP
    Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
    Héron-Milhavet L; Franckhauser C; Rana V; Berthenet C; Fisher D; Hemmings BA; Fernandez A; Lamb NJ
    Mol Cell Biol; 2006 Nov; 26(22):8267-80. PubMed ID: 16982699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
    Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
    Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
    Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
    Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of functional domains in AKT responsible for distinct roles of AKT isoforms in pressure-stimulated cancer cell adhesion.
    Wang S; Basson MD
    Exp Cell Res; 2008 Jan; 314(2):286-96. PubMed ID: 17825284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
    Haslinger P; Haider S; Sonderegger S; Otten JV; Pollheimer J; Whitley G; Knöfler M
    Biol Reprod; 2013 Mar; 88(3):54. PubMed ID: 23303682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo.
    Sasaki T; Nakashiro K; Tanaka H; Azuma K; Goda H; Hara S; Onodera J; Fujimoto I; Tanji N; Yokoyama M; Hamakawa H
    Biochem Biophys Res Commun; 2010 Aug; 399(1):79-83. PubMed ID: 20638364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
    Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
    Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
    Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
    Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
    Liu S; Yamauchi H
    Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH
    Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells.
    Santi SA; Lee H
    PLoS One; 2011 Jan; 6(1):e14614. PubMed ID: 21297943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
    Riggio M; Perrone MC; Polo ML; Rodriguez MJ; May M; Abba M; Lanari C; Novaro V
    Sci Rep; 2017 Mar; 7():44244. PubMed ID: 28287129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
    Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
    Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.